Replies to post #802072 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Investors like me did not know until recently that #1 (below) was messed up up by manufacturer Fikst, and apparently finally cured by another manufacturer, imo, effectively, around November 20, 2025, imo, because that’s when C suite construction started.

1. The GMP compliant design and post approval comparability plan were needed for the MAA.

2. The actual comparability testing is accomplished post approval.